We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Feather Safety Razor

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Innovative Implant Treats Lumbar Spinal Stenosis

By HospiMedica International staff writers
Posted on 18 Sep 2018
Print article
Image: An interlaminar device helps stabilize the stenotic spine (Photo courtesy of Paradigm Spine).
Image: An interlaminar device helps stabilize the stenotic spine (Photo courtesy of Paradigm Spine).
A non-fusion, motion-preserving implant used following decompression procedures helps stabilize the lumbar spine without resorting to fusion.

The Paradigm Spine (New York, NY, USA) coflex device is a small, U-shaped interlaminar titanium stabilization device indicated for use after a spinal decompression procedure on one or two level contiguous lumbar motion segments (L1-L5) in skeletally mature patients, with at least moderate impairment in function, who experience relief during flexion from leg, buttocks, or/and groin pain (with or without back pain), and who previously underwent at least six months of non-operative treatment. The device is implanted midline between adjacent lamina, and is available in five different anatomical sizes.

During the clinical procedure, the “U” is positioned horizontally, with the apex oriented anteriorly and the two long side arms paralleling the long axis of the spinous processes. The bone-facing surfaces are ridged to provide resistance to migration. Features include a biocompatible and x-ray visible titanium composition; crimped wings for increased primary stability; a center of rotation close to the spinal canal to provide increased rotational stability; stress reduction on facet joints; a large contact area for optimized stress distribution; protection of posterior elements; and maintenance of foraminal height.

“There is now potentially a more effective surgical option between the two typical treatments for lumbar spinal stenosis, and we are proud to lead the way in changing the standard of care for surgeons and their patients with this diagnosis,” said Marc Viscogliosi, chairman and CEO of Paradigm Spine. “Paradigm Spine has worked diligently to build the pieces of the puzzle in establishing coflex as the new standard of care for the treatment of moderate to severe lumbar spinal stenosis.”

Lumbar spinal stenosis is a debilitating and degenerative disease in older patients, often associated with significant leg and back pain, leg numbness, and weakness, which causes a significant reduction activity. Decompression alone is effective at relieving pain symptoms caused by lumbar spinal stenosis, but long term symptomatic relief is elusive, often resulting in subsequent opioid pain control, epidural injections for pain management, or additional surgeries for conversion to a fusion. Decompression with fusion has proven to provide pain relief and stabilize the diseased segment, but may lead to adjacent level disease requiring subsequent surgeries.

Related Links:
Paradigm Spine


Print article

Channels

Critical Care

view channel
Image: Triage Cardiac Panel is a rapid, POC fluorescence immunoassay used with Triage MeterPro (Photo courtesy of Quidel)

Quidel Triage Cardiac Panel Facilitates Rapid POC Diagnosis of Chest Pain Patients in ED

Chest and abdominal pain are the most common reasons that persons aged 15 years and over visit the emergency department (ED). Because both emergency and non-emergency care are provided, symptoms vary widely... Read more

Patient Care

view channel
Image: Future wearable health tech could measure gases released from skin (Photo courtesy of Pexels)

Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases

Most research on measuring human biomarkers, which are measures of a body’s health, rely on electrical signals to sense the chemicals excreted in sweat. But sensors that rely on perspiration often require... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.